Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.

1. We examined the effects of eprosartan, an AT(1) receptor antagonist, on the progression of left ventricular (LV) dysfunction and remodelling in dogs with heart failure (HF) produced by intracoronary microembolizations (LV ejection fraction, EF 30 to 40%). 2. Dogs were randomized to 3 months of oral therapy with low-dose eprosartan (600 mg once daily, n=8), high-dose eprosartan (1200 mg once daily, n=8), or placebo (n=8). 3. In the placebo group, LV end-diastolic (EDV) and end-systolic (ESV) volumes increased after 3 months (68+/-7 vs 82+/-9 ml, P<0.004, 43+/-1 vs 58+/-7 ml, P<0.003, respectively), and EF decreased (37+/-1 vs 29+/-1%, P<0.001). In dogs treated with low-dose eprosartan, EF, EDV, and ESV remained unchanged over the course of therapy, whereas in dogs treated with high-dose eprosartan, EF increased (38+/-1 vs 42+/-1%, P<0.004) and ESV decreased (41+/-1 vs 37+/-1 ml, P<0.006), Eprosartan also decreased interstitial fibrosis and cardiomyocyte hypertrophy. 4. We conclude that eprosartan prevents progressive LV dysfunction and attenuates progressive LV remodelling in dogs with moderate HF and may be useful in treating patients with chronic HF.
AuthorsGeorge Suzuki, Takayuki Mishima, Elaine J Tanhehco, Victor G Sharov, Anastassia Todor, Sharad Rostogi, Ramesh C Gupta, Pervaiz A Chaudhry, Petros V Anagnostopoulos, Omar Nass, Sidney Goldstein, Hani N Sabbah
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 138 Issue 2 Pg. 301-9 (Jan 2003) ISSN: 0007-1188 [Print] England
PMID12540520 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Acrylates
  • Angiotensin Receptor Antagonists
  • Imidazoles
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin
  • Thiophenes
  • eprosartan
  • Acrylates (pharmacology, therapeutic use)
  • Angiotensin Receptor Antagonists
  • Animals
  • Disease Progression
  • Dogs
  • Heart Failure (drug therapy, physiopathology)
  • Imidazoles (pharmacology, therapeutic use)
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin (physiology)
  • Thiophenes
  • Ventricular Dysfunction, Left (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: